After a lukewarm debut last week, Sony’sVenom: The Last Dancewill top another low-performing weekend at the domestic box office. The superhero film grossed an underwhelming $51 million in its first three days of release, and is all set to top the charts for the second time in a row, despite a hefty fall.Venom: The Last Danceearned over $6.6 million on its second Friday, taking its running haul to $70 million. This also puts the movieon course for a sophomore frame of around $20 million. The weekend-on-weekend drop-off is going to be on the higher side, which aligns with theso-so audience receptionthat the film was greeted with.
If these projections hold,Venom: The Last Dancewill pass the $80 million mark by Sunday. It’ll most probably pass the $100 million milestone as well, but there’s no chance of it matching the first and second films’ near-identical lifetime hauls. BothVenomand its sequel,Venom: Let There Be Carnage, concluded their domestic runs with $213 million. The films were also successful internationally, and combined, theVenom trilogy has already generated over $1.5 billion worldwide.Venom: The Last Dancewill also have to rely on foreign markets in the coming weeks, particularly China, where the film is exceeding all expectations.
Debuting just inside the top five is directorRobert Zemeckis’Here, which reunites him with hisForrest GumpstarsTom HanksandRobin Wright. The high-concept drama, which follows a family across decades through a static camera stationed in exactly one spot, is coming up short of its $7 million projections. The film isexpected to gross around $5 million across the weekend, after generating $1.9 million on Friday. Of this total, less than $500,000 came from Thursday previews.Herecost a reported $50 million to produce, and marks Zemeckis' first theatrical release in six years.
Meanwhile, ‘The Wild Robot’, ‘Conclave’ and ‘Smile 2’ All Exceeded Expectations
Hoping to jump up a spot in its sixth weekend of release, DreamWorks’The Wild Robotis eying around $6 million after generating $1.8 million on Friday. The universally acclaimed film — it has a 98% approval rating on the aggregator website Rotten Tomatoes — is displaying extraordinary legs, despite having been released on PVOD platforms weeks ago. Thefilm will hit the $120 million mark domestically by Sundayif projections hold. It’ll compete for the second spot this weekend with the horror sequelSmile 2, which is looking to gross over $6 million as well, after generating just under $2 million on its third Friday. By Sunday, the film will finally scrape past the $50 million milestone. By comparison, the sensational first film legged it past the $100 million mark. Although it has received stellar reviews,Smile 2is coming up considerably short of its predecessor.
The top five was rounded off by the unexpectedly robustConclave, which generated around $1.5 million on its second Friday, and is expected to gross over $4 million across the weekend. Thispushes the film past the $10 million mark; it’ll come within touching distance of the $15 million milestone by Sunday. StarringRalph Fiennesand directed byEdward Berger,Conclaveis still playing in a relatively limited release. Elsewhere, the romantic dramaWe Live in Timepassed the $15 million milestone domestically after generating a healthy $1 million on its fourth Friday. Stay tuned to Collider for more updates.
Venom: The Last Dance
Eddie Brock, balancing life with the alien symbiote Venom, faces a complex struggle with a powerful new adversary threatening their existence and the world. As a turbulent alliance forms between man and symbiote, the duo embarks on a thrilling journey of survival, challenging their limits and ethical boundaries.
Find tickets
